Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test
Saved in:
| Title: | Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test |
|---|---|
| Authors: | Metamark Genetics, Inc. |
| Source: | Business Wire (English). 01/06/2016. |
| Abstract: | Metamark Genetics, Inc. (“Metamark”), a leader in developing and commercializing high-value urologic oncology products, today announced that it has entered into a collaboration agreement with Hologic (Nasdaq: HOLX), pursuant to which Metamark will serve as the exclusive worldwide sales agent of Hologic’s Progensa® PCA3 assay. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Metamark Genetics, Inc. (“Metamark”), a leader in developing and commercializing high-value urologic oncology products, today announced that it has entered into a collaboration agreement with Hologic (Nasdaq: HOLX), pursuant to which Metamark will serve as the exclusive worldwide sales agent of Hologic’s Progensa® PCA3 assay. [ABSTRACT FROM PUBLISHER] |
|---|
